These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32068117)

  • 1. Dividing subpopulation of Escherichia coli in stationary phase.
    Jõers A; Liske E; Tenson T
    Res Microbiol; 2020; 171(3-4):153-157. PubMed ID: 32068117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell division in Escherichia coli cultures monitored at single cell resolution.
    Roostalu J; Jõers A; Luidalepp H; Kaldalu N; Tenson T
    BMC Microbiol; 2008 Apr; 8():68. PubMed ID: 18430255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of a Thermosensitive
    Vega DE; Margolin W
    J Bacteriol; 2018 Jan; 200(2):. PubMed ID: 29061666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of cell size and DNA content in exponentially growing and stationary-phase batch cultures of Escherichia coli.
    Akerlund T; Nordström K; Bernander R
    J Bacteriol; 1995 Dec; 177(23):6791-7. PubMed ID: 7592469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous mutagenesis in exponentially growing and stationary-phase, umuDC-proficient and -deficient, Escherichia coli dnaQ49.
    Nowosielska A; Nieminuszczy J; Grzesiuk E
    Acta Biochim Pol; 2004; 51(3):683-92. PubMed ID: 15448730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of phase variation of type 1 fimbriae in a uropathogenic Escherichia coli cystitis isolate during urinary tract infection.
    Snyder JA; Lloyd AL; Lockatell CV; Johnson DE; Mobley HL
    Infect Immun; 2006 Feb; 74(2):1387-93. PubMed ID: 16428790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli.
    Li Y; Zhang Y
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2092-9. PubMed ID: 17420206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA synthesis and viability of a mutT derivative of Escherichia coli WP2 under conditions of amino acid starvation and relation to stationary-phase (adaptive) mutation.
    Bridges BA; Ereira S
    J Bacteriol; 1998 Jun; 180(11):2906-10. PubMed ID: 9603880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the flhD gene of Escherichia coli K-12 do not cause the reported effect on cell division.
    Siegele DA; Bain S; Mao W
    FEMS Microbiol Lett; 2010 Aug; 309(1):94-9. PubMed ID: 20546312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell division in Escherichia coli minB mutants.
    Akerlund T; Bernander R; Nordström K
    Mol Microbiol; 1992 Aug; 6(15):2073-83. PubMed ID: 1406249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transposon mutagenesis identifies genes which control antimicrobial drug tolerance in stationary-phase Escherichia coli.
    Hu Y; Coates AR
    FEMS Microbiol Lett; 2005 Feb; 243(1):117-24. PubMed ID: 15668009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-specific effects of antisense phosphorodiamidate morpholino oligomer-peptide conjugates on Escherichia coli and Salmonella enterica serovar typhimurium in pure culture and in tissue culture.
    Tilley LD; Hine OS; Kellogg JA; Hassinger JN; Weller DD; Iversen PL; Geller BL
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2789-96. PubMed ID: 16870773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli.
    Sandegren L; Lindqvist A; Kahlmeter G; Andersson DI
    J Antimicrob Chemother; 2008 Sep; 62(3):495-503. PubMed ID: 18544599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial persistence as a phenotypic switch.
    Balaban NQ; Merrin J; Chait R; Kowalik L; Leibler S
    Science; 2004 Sep; 305(5690):1622-5. PubMed ID: 15308767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of Toxic Volatile Compounds in Batch Culture Prolongs Stationary Phase and Delays Death of Escherichia coli.
    Osborne MG; Geiger CJ; Corzett CH; Kram KE; Finkel SE
    Appl Environ Microbiol; 2021 Nov; 87(24):e0186021. PubMed ID: 34613759
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Behringer MG; Choi BI; Miller SF; Doak TG; Karty JA; Guo W; Lynch M
    Proc Natl Acad Sci U S A; 2018 May; 115(20):E4642-E4650. PubMed ID: 29712844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persisters: a distinct physiological state of E. coli.
    Shah D; Zhang Z; Khodursky A; Kaldalu N; Kurg K; Lewis K
    BMC Microbiol; 2006 Jun; 6():53. PubMed ID: 16768798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic Antimicrobial Activity of Colistin in Combination with Rifampin and Azithromycin against Escherichia coli Producing MCR-1.
    Li Y; Lin X; Yao X; Huang Y; Liu W; Ma T; Fang B
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocalorimetry Reveals the Growth Dynamics of Escherichia coli Cells Undergoing Adaptive Evolution during Long-Term Stationary Phase.
    Robador A; Amend JP; Finkel SE
    Appl Environ Microbiol; 2019 Aug; 85(15):. PubMed ID: 31152016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial competition: Escherichia coli mutants that take over stationary phase cultures.
    Zambrano MM; Siegele DA; Almirón M; Tormo A; Kolter R
    Science; 1993 Mar; 259(5102):1757-60. PubMed ID: 7681219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.